• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE 5 SYS W/PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE 5 SYS W/PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX816T
Medical Device Problem Code Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 01/24/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a m.Blue shunt system (part # fx816t) was implanted during a procedure performed on (b)(6) 2021.According to the complainant, the shunt system was believed to be operated in underdrainage.The patient underwent a revision procedure performed on (b)(6) 2023.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 1 year, 6 month, height: 80 centimeters (cm), weight: 9 kilograms (kg), gender: female.
 
Additional Manufacturer Narrative
Investigation: visual inspection: the following observations were made during the visual inspection: tissue residues in the pediatric control reservoir.Scratches on the outer housing of the m.Blue.Permeability test: the test showed that the m.Blue shunt system is non-permeable.To determine the location of the occlusion, the system was dismantled and each element was tested individually for permeability.The test showed that the m.Blue is non-permeable, whereas the pediatric control reservoir is permeable.Particles were flushed from the reservoir during the test.Computer control test: to check the flow rate of the valve,the valve was tested on a miethke computer -controlled testing apparatus and passed the standard test.The flow of the test liquid was reduced step by step from 60 ml/h to 5 ml/h (in accordance with iso 7197).Distilled water was used as the test-liquid.The resulting pressure was measured.Due to the non-permeability of the m.Blue valve, the computer-controlled test was not applicable.Adjustability test: the m.Blue was found to be non-adjustable within the specified range.Braking force and brake function test: the braking force test indicates that the brake function of the m.Blue® is present.Due to the non-adjustability of the valve, as detailed in section adjustability test, an investigation of the braking force was not possible.Internal inspection of product: after dismantling of the valve, deposits were found in m.Blue.Results: for the sake of thoroughness and transparency, we would like to point out that a permeability test was already carried out after the revision at the hospital.Based on our investigation results, we have determined that there was a blockage and a non-adjustability in the valve at the time of our investigation.Detected deposits could be named as the cause of the functional deviations.Existing deposits in the csf can temporarily impair the function of the valve and is described as concomitant symptoms in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE 5 SYS W/PED.CONTROL RESERVOIR
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key16518400
Report Number3004721439-2023-00048
Device Sequence Number12317351
Product Code JXG
UDI-Device Identifier04041906504526
UDI-Public4041906504526
Combination Product (Y/N)N
Initial Reporter CountryLO
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/19/2026
Device Model NumberFX816T
Device Catalogue NumberFX816T
Device Lot Number20053410
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/09/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/09/2023
Initial Report FDA Received Date03/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/02/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age18 MO
Patient SexFemale
Patient Weight9 KG
-
-